Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Defensive Interval Ratio
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Defensive Interval Ratio of 619 days as of December 2024. Defensive assets of $1.35K (cash $-, short-term investments $1.35K, receivables $-) cover 619 days of daily cash needs of $2.18/day. Check tangible equity quality of Drugs Made In America Acquisition Corp. to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Drugs Made In America Acquisition Corp. Ordinary Shares Defensive Interval Ratio (2024–2024)
This chart shows how Drugs Made In America Acquisition Corp. Ordinary Shares's Defensive Interval Ratio has evolved across 1 annual periods from 2024 to 2024. As of December 2024, the ratio stands at 619 days, meaning defensive assets of $1.35K can fund 619 days of operations without new revenue. Read DMAA liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Drugs Made In America Acquisition Corp. Ordinary Shares (2024–2024)
The table below presents the year-by-year Defensive Interval Ratio for Drugs Made In America Acquisition Corp. Ordinary Shares from 2024 to 2024, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Drugs Made In America Acquisition Corp. (DMAA) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 619 days | $1.35K | $2.18/day | $- | $1.35K | — |